Product innovations > Supplier info centre
ScinoPharm - Your Complete Source for API Services
ScinoPharm is among the global leaders in the development and manufacture of high-quality active pharmaceutical ingredients (API). The company supports drug development and manufacturing with a full range of API services from process development, production of early phase clinical trial material to large-scale manufacuring for commercial launches.
Headquartered in Taiwan, ScinoPharm operates a cGMP facility in full compliance with regulatory standards of US, EU, Japan, Australia, Korea, etc. Out of the 16 manufacturing lines, 6 are capable of handling high potency, cytotoxic compounds including many injectable oncological APIs.
At ScinoPharm, R&D has always been seen as essential to future development. The company also focuses on the development of advanced technologies in the fields of peptides and biopharmaceuticals.
To address the demands of both multinational companies and local formulation companies, ScinoPharm is constructing a new GMP plant in Changshu, Jiangsu Province, China to provide a wide range of cost-competitive development and manufacturing solutions for key intermediates and APIs.
Combining cost-effective resources and productivity of Asia along with unmatched regulatory know-how, ScinoPharm is uniquely positioned to serve global pharmaceutical R&D and manufacturing needs at any level and for any company in this sector, with over 285 customers around the world including many of the world’s largest brand and generic drug makers.
